Ipratropium
Bromide
 |
|
35A023,Ipratropium bromide 0.5 mg/2 ml/Amp.
現行藥物外觀
中文名: 定喘樂單一劑量吸入液
廠牌:BOEHRINGER INGELHEI
|
| Product
name |
|
| Dosage
form |
|
| Indications |
| Bronchitis; pulmonary emphysema; COPD |
|
| Administration
& Dosage |
| Bronchitis; pulmonary emphysema; COPD:
MDI: 2-4 inhalations TID-QID, up to 6-8 inhalations TID. For severe exacerbations, 6-8 inhalations using a spacer device, q3-4h.
Inhalation solution:0.25-0.5 mg, diluted, if necessary; administered via nebulization Q6-8h. For severe exacerbations of COPD, 0.5 mg may be administered Q4-8h. Max. 2 mg/d.
|
|
| Contraindication |
|
| Precaution |
|
| Adverse
reaction |
| M: Cough; dryness of mouth; unpleasant taste
R: Bronchospasm; dermatitis; angioedema; skin rash; urticaria; eye pain; paralytic ileus; blurred vision; dizziness; headache; nausea; nervousness; palpitations; sweating; trembling; urinary retention
|
|
| Drug
Interaction |
|
| Pregnancy
Category |
|
| Notes |
| Diluted with preservative-free sterile 0.9 % sodium chloride. |
|
